Canadian Task Force on Preventive Health Care

Selected References

Preventive Health Care, 2001 update: Screening for
cognitive impairment and dementia in the elderly

Prepared by Christopher J.S. Patterson, MD, FRCPC, Professor, Division of Geriatric Medicine, McMaster University, Hamilton, Ontario and David A. Gass, MD, Department of Family Medicine, Dalhousie University, Halifax, Nova Scotia.

These recommendations were finalized by the Task Force in 1999.

  1. Whitby L. Screening for disease - definitions and criteria. Lancet. 1974; ii: 819-821.
  2. Patterson C, Gauthier S, Bergman H, et al. The recognition, assessment and management of dementing disorders: conclusions from the Canadian Consensus Conference on Dementia. Can Med Assoc J 1999; 160 (Suppl 12): S1-S16.
  3. Lezak MD. Neuropsychological Assessment. New York. Oxford University Press. 1976; p. 14.
  4. Wilson JMC, Jungner G. Principles and Practice of Screening for Disease. Public Health Paper. No. 34. WHO. Geneva. 1968.
  5. Canadian Study of Health & Aging Working Group. Canadian study of health & aging: study methods and prevalence of dementia. Can Med Assoc J 1994; 150(6): 899-913.
  6. Canadian Study of Health & Aging Working Group. The incidence of dementia in Canada. Neurology 2000; 55: 66-73.
  7. Graham JE, Rockwood K, Beattie BL, Eastwood R, Gauthier S, Tuokko H,  McDowell I. Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 1997; 349: 1793-1796.
  8. Small G, Ivnik RJ, Petersen RC, et al. Age-associated memory impairment diagnoses: problems of reliability and concerns for terminology. Psychol Aging. 1991; 6: 551-558.
  9. Reisberg B, Ferris S, DeLeon M, Crook T.  The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry. 1982; 139: 1136-1139.
  10. Jorm AF, Christensen H, Korten AE, et al.  Do cognitive complaints either predict future cognitive decline or reflect past cognitive decline?  A longitudinal study of an elderly community sample.  Psychological Medicine.  1997; 27: 91-98.
  11. Jonker C, Launer LJ, Hooijer C, Lindeboom J.  Memory complaints and memory impairment in older individuals. J Am Geriatr Soc. 1996; 44: 44-49.
  12. Tobiansky R, Blizard R, Livingston G, Mann A.  The Gospel Oak Study Stage IV:  the clinical relevance of subjective memory impairment in older people. Psychol Med. 1995; 25: 779-786.
  13. Hänninen T, Reinikainen KJ, Helkala E-L, et al. Subjective memory complaints and personality traits in normal elderly subjects. J Am Geriatr Soc. 1994; 42: 1-4.
  14. Christensen H, Henderson AS, Korten AE, et al.  ICD-10 Mild cognitive disorder:  its outcome three years later. Int J Geriatr Psychiatr. 1997; 12: 581-586.
  15. Devenand DP, Folz M, Gorlyn M, Moeller JR, Stern Y.  Questionable dementia:  clinical course and predictors of outcome.  J Am Geriatr Soc.  1997; 45: 321-328.
  16. Petersen RC. Mild cognitive impairment or questionable dementia? Arch Neurol 2000; 57: 643-644.
  17. Ritchie K, Leibovici D, Ledésert B, Touchon J.  A typology of sub-clinical  senescent cognitive disorder.  Br J Psychiatr.  1996; 168: 470-476.
  18. Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56: 303-308.
  19. Tierney MC, Szalai JP, Snow WG, Fisher RH.  The prediction of Alzheimer's disease.  Arch Neurol.  1996; 53: 423-427.
  20. Masur DM, Sliwinski M, Lipton RB, Blau AD, Crystal HA.  Neuropsychological prediction of dementia and the absence of dementia in health elderly persons.  Neurology 1994; 44: 1427-1432.
  21. Folstein MF, Folstein SE, McHugh PR.  Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician.  Journal of Psychiatric Research.  1975; 12: 189-198.
  22. Braekus A, Laake K, Engedal K.  A Low, “Normal” Score on the Mini-Mental State Examination predicts development of dementia after three years.  J Am Geriatr Soc.  1995; 43: 656-661.
  23. Ferrucci L, Cecchi F, Guralnik JM, et al for the FINE Study Group.  Does the clock drawing test predict cognitive decline in older persons independent of the Mini-Mental State Examination?  J Am Geriatr Soc.  1996; 44: 1326-1331.
  24. Schmand B, Jonker C, Hooijer C, Lindeboom J.  Subjective memory complaints may announce dementia.  Neurology.  1996; 46: 121-125.
  25. Schofield PW, Marder K, Dooneief G, Jacobs DM, Sano M, Stern Y.  Association of subjective memory complaints with subsequent cognitive decline in community-dwelling elderly individuals with baseline cognitive impairment .  Am J Psychiatry.  1997; 154: 609-615.
  26. Hogan DB, Ebly EM. Predicting who will develop dementia in a cohort of Canadian seniors. Can J Neurol Sci 2000; 27: 18-24.
  27. Petersen RC, Smith GE, Ivnik RJ et al.  Apolipoprotein E status as a predictor of the development of Alzheimer’s disease in memory-impaired individuals.  J Am Med Assoc.  1995; 273: 1274-1278.
  28. Tierney MC, Szalai JP, Snow WG, et al. A prospective study of the clinical utility of ApoE genotype in the prediction of outcome in patients with memory impairment.  Neurology. 1996a; 46: 149-154.
  29. Tierney MC, Szalai JP, Snow WG, et al. Prediction of probable Alzheimer’s disease in memory-impaired patients:  a prospective longitudinal study.  Neurology. 1996c; 46: 661-665.
  30. Small, GW, La Rue, A, Komo S, Kaplan A, Mandelkern MA.  Predictors of cognitive change in middle-aged and older adults with memory loss.  Am J Psychiatry.  1995; 152: 1757-1764.
  31. Jorm AF, Christensen H, Henderson AS, et al. Cognitive complaints of cognitive decline in the elderly:  a comparison of reports by subjects and informants in a community survey.  Psychological Medicine.  1994; 24: 365-374.
  32. Stern Y, Gurland B, Tatemichi TK, Tang MX, Wilder D, Mayeux R.  Influence of education and occupation on the incidence of Alzheimer’s disease.  JAMA.  1994; 271: 1004-1010.
  33. Clarfield AM. The reversible dementias: do they reverse? Ann Intern Med 1988; 109: 476-486.
  34. Mittelman MS, Ferris SH, Shulman E, Steinberg G, Levin B.  A family intervention to delay nursing home placement of patients with Alzheimer disease:  a randomized controlled trial.  J Am Med Assoc.  1996; 276: 1725-1731.
  35. O’Connor DW, Pollitt PA, Brook CPB, Reiss BB, Roth M.  Does early intervention reduce the number of elderly people with dementia admitted to institutions for long term care?  BMJ; 1991; 302: 871-5.
  36. Mulnard RA, Cotman CW, Kawas C, et al. Estrogen replacement therapy for treatment of mild to moderate Alzheimer's Disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. JAMA 2000; 283(8): 1007-1015.
  37. Crook TH, Tinklenberg J, Yesavage J et al.  Effects of phosphatidyl serine in age-associated memory impairment.  Neurology.  1991; 41: 644-649.
  38. Israel L, Melac M, Milinkevitch D, et al.  Drug therapy and memory training programs:  a double-blind randomized trial of general geriatric patients with age-associated memory impairment.  Int Psychogeriatr.  1994; 6: 155-170.
  39. McEntee WJ, Crook TH, Jenkyn LR et al.   Treatment of age-associated memory impairment with guanfacine.  Psychopharm Bull.  1991; 27: 41-46.
  40. Rogers SL, Friedhoff LT and the Donepezil Study Group.  The efficacy and safety of donepezil in patients with Alzheimer’s disease:  results of a US multicenter, randomized double-blind, placebo-controlled trial.  Dementia.  1996; 7: 293-303.
  41. Rogers SL, Farlow MR, Doody RS, Mohs R, Friedhoff LT and the Donepezil Study Group.  A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer’s disease.  Neurology.  1998; 50: 136-145.
  42. Rosler M, Anand R, Cicin-Sain A, et al on behalf of the B303 Exelon Study Group. Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomized controlled trial. Br Med J 1999; 318: 633-640.
  43. Nordberg A, Svensson A-L. Cholinesterase inhibitors in the treatment of Alzheimer's disease. A comparison of tolerability and pharmacology. Drug Safety 1998; 19(6): 465-480.
  44. Hux MJ, O’Brien BJ, Iskedjian M, et al.  Relation between severity of Alzheimer’s disease and costs of caring.  CMAJ.  1998; 159:  457-65.
  45. Sano M, Ernesto C, Thomas RG, et al.  A controlled trial of selegiline, alpha tocopherol or both as treatment for Alzheimer’s disease.  The Alzheimer’s Disease Cooperative Study.  N Eng J Med.  1997; 336: 1216-1222.
  46. Flicker L, Logiudice D, Carlin JB, Ames D.  The predictive value of dementia screening instruments in clinical populations.  Int J Geriat Psychiatry.  1997; 12: 203-209.
  47. Jorm AF, Jacomb PA.  The informant questionnaire on cognitive decline in the elderly.  (IQCODE).  Socio-demographic correlates, reliability, validity, and some norms.  Psychol Med.  1989; 19: 1015-1022.
  48. Jorm AF.  Assessment of cognitive impairment and dementia using informant reports.  Clin Psychol Rev. 1996; 16.
  49. Jorm AF, Christensen H, Henderson AS, et al.  Informant ratings of cognitive decline of elderly people: relationship to longitudinal change on cognitive tests.  Age Ageing.  1996; 25: 125-129.
  50. Jorm  AF.  Methods of screening for dementia:  A meta-analysis of studies comparing an informant questionnaire with a brief cognitive test.  Alzheimer Dis Assoc Disord.  1997; 11: 158-62.
  51. Barberger-Gateau P, Commenges D, Gagnon M, et al.  Instrumental activities of daily living as a screening tool for cognitive impairment and dementia in elderly community dwellers.  J Am Geriatr Soc.  1992; 40: 1129-1134.
  52. Tombaugh TN, McIntyre NJ.  The Mini-Mental State Examination:  A comprehensive review.  J Am Geriatric Soc.  1992; 40: 992-935.
  53. O'Connor DW, Pollitt PA, Treasure FP, Brook CPB, Reiss BB. The influence of education, social class, and sex on Mini-Mental State Scores. Psychol Med 1989; 19: 771-776.
  54. Kitner SJ, White LR, Farmer ME, et al. Methodological issues in screening for dementia: the problem of education adjustment. J Chronic Dis 1986; 39: 163-170.
  55. Bleeker ML, Bolla-Wilson K, Kawas C, Agnew J. Age-specific norms for the Mini-Mental State Examination. Neurology 1988; 38: 1565-1568.
  56. Tangalos EG, Smith GE, Ivnik RJ, et al.  The Mini-Mental State Examination in general medical practice:  Clinical Utility and Acceptance.  Mayo Clin Proc.  1996; 71: 829-837.
  57. Wind AW, Schellevis FG, Van Staveren G, et al.  Limitations of the Mini-Mental State Examination in diagnosing dementia in general practice.  Int J Geriat Psychiatry.  1997; 12: 101-108.
  58. Wells JC, Keyl PM, Chase GA, et al. Discriminant validity of a reduced set of Mini-Mental State Examination items for dementia and Alzheimer's disease. Acta Psychiatr Scand 1992; 86: 23-31.
  59. Feher EP, Mahurin RK, Doody RS, et al. Establishing the limits of the Mini-Mental State. Examination of "subtests". Arch Neurol 1992; 49: 87-92.
  60. Cossa FM, Sala SD, Musicco M, Spinnler H, Ubezio MC. Comparison of two scoring systems of the Mini-Mental State Examination as a screening test for dementia. J Clin Epidemiol 1997; 50(8): 961-965.
  61. Christensen H, Hadzi-Pavlovic D, Jacomb P.  The psychometric differentiation of dementia from normal aging.  Psychol Assess.  1991; 3: 147-155.
  62. Stuss DT, Meiran N, Guzman DA, Lafleche G, Willmer J.  Do long tests yield a more accurate diagnosis of dementia than short tests? A comparison of 5 neuropsychological tests.  Archives of Neurology 1996 Oct; 53(10): 1033-9.
  63. Malloy PF, Cummings JL, Coffey CE, et al. Cognitive screening instruments in neuropsychiatry: a report of the committee on research of the American Neuropsychiatry Association. J Neuropsychiatry Clin Neurosci 1997; 9(2): 189-197.
  64. Robertson D, Rockwood K, Stolee P.  A short mental status questionnaire.  Can J Aging.  1982; 1: 16-20.
  65. Worral G, Moulton N.  Cognitive Function:  Survey of elderly persons living at home in rural Newfoundland.  Can Fam Physician.  1993; 39: 772-777.
  66. Pfeiffer E.  A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients.  J Am Geriatr Soc.  1975; 23: 433-41.
  67. Callahan CM, Hendrie HC, Tierney WM.  Documentation and evaluation of cognitive impairment in elderly primary care patients.  Ann Intern Med.  1995; 122: 422-429.
  68. Evans DA, Funkenstein HH, Albert MS et al.. Prevalence of Alzheimer’s disease in a community population of older persons.  J Am Med Assoc.  1989; 262: 2551-2556.
  69. Folstein MF, Anthony JC, Parhad I et al.  The meaning of cognitive impairment in the elderly.  J Am Geriatr Soc.  1985; 33: 228-235.
  70. Teng EL, Chui HC.  The Modified Mini-Mental State (3 MS) Examination.  J. Clin Psychiatry.  1987; 48: 314-318.
  71. Ebly EM, Hogan DB, Parhad IM. Cognitive impairment in the nondemented elderly. Arch Neurol. 1995;52:612-19.
  72. Gale CR, Martyn CN, Cooper C.  Cognitive impairment and mortality in a cohort of elderly people.  BMJ.  1996; 312: 608-611.
  73. Erkinjuntti T, Ostbye T, Steenhuis R, Hachinski V. The effect of different diagnostic criteria on the prevalence of dementia. N Engl J Med 1997; 337: 1667-1674.
  74. Marshall KG.  Prevention.  How much harm?  How much benefit?  3. Physical, psychological and social harm.  Can Med Assoc J.  1196; 155(2): 169-176.
  75. Lasoski MC, Thelen MH.  Attitudes of older and middle aged persons towards mental health intervention.  Gerontologist.  1987; 27: 288-292.
  76. Hutchinson B, Woodward CA, Norman GR, Abelson J, Brown JA. Provision of preventive care to unannounced standardized patients. Can Med Assoc J 1998; 158: 185-193.
  77. Busch C, Kozak J, Elmslie T.  Screening for cognitive impairment in the elderly.  Can Fam Physician.  1997; 43: 1763-1768.
  78. Tangalos EG, Smith GE, Ivnik RJ, et al. The Mini-Mental State Examination in general medical practice: clinical utility and acceptance. Mayo Clin Proc 1996; 71: 829-837.
  79. Rubenstein LV, Calkins DR, Young RT, et al. Improving patient function: a randomized trial of functional disability screening. Ann Intern Med 1989; 111: 836-842.
  80. US Preventive Services Task Force.  Screening for dementia in:  Guide to Clinical Preventive Services 2nd Edition.  Alexandria, Virginia:  International Medical Publishing.  1996; p. 531-540.
  81. Canadian Task Force on the Periodic Health Examination.  The Canadian Guide to Clinical Preventive Health Care.  Ed. Goldbloom R.  Ottawa.  Canada Communication Group.  1994.  p. 902-911.
  82. Rubenstein LV, Calkins DR, Greenfield S, et al.  Health Status Assessment for Elderly Patients:  Report of the Society of General Internal Medicine Task Force on Health Assessment.  J Am Geriatr Soc.  1989; 37: 562-9.
  83. American Psychiatric Association Committee on Nomenclature and Statistics.  Diagnostic and Statistical Manual of Mental Disorders, 4th Ed.  Washington, D.C.: American Psychiatric Association, 1994.
  84. World Health Organization.  The ICD-10 Classification of Mental and Behavioural Disorders.  Diagnostic Criteria for Research.  Geneva: World Health Organization. 1993.
  85. Morris JC, McManus DQ.  The neurology of aging:  normal vs. pathological change.  Geriatrics.  1991; 46: 47-48.
  86. Forstl H, Hentschel F, Sattel H, et al.  Age-associated memory impairment and early Alzheimer’s disease.  Only time will tell the difference.  Arzneimittelforschung. 1995; 45: 394-397.
  87. Larrabee GJ, Crook TH.  Estimated prevalence of age-associated memory impairment derived from standardized tests of memory function. Int Psychogeriatr. 1994;6:95-104.
  88. Crook T, Bartus RT, Ferris SH, et al.  Age-associated memory impairment:  proposed diagnostic criteria and measures of clinical change-report of a National Institute of Mental Health Work Group.  Developmental Neuropsychology.  1986; 2: 261-276.
  89. Kral VA.  Senescent forgetfulness:  benign and malignant.  Can Med Assoc J.  1962; 86: 257-260.
  90. Barker A, Jones R, Jennison C. A prevalence study of age-associated memory impairment. British Journal of Psychiatry. 1995;167:642-8.
  91. Hänninen T, Hallikainen M, Koivisto K, et al.  A follow-up study of age-associated memory impairment neuropsychological predictors of dementia.  J Am Geriatr Soc.  1995;43:1007-15.
  92. O’Brien JT, Beats B, Hill K, et al.  Do subjective memory complaints precede dementia?  A three-year follow-up of patients with supposed “benign senescent forgetfulness”.  Intl J Geriatr Psychiatry.  1992;7:481-6.
  93. Bowen J, Teri L, Lukull W, et al.  Progression to Dementia in Patients with Isolated Memory Loss.  Lancet.  1997; 349(9054): 763-765.
  94. Petersen RC, Smith GE, Waring SC, et al.  Aging memory and mild cognitive impairment.  International Psychogeriatrics.  1997; 9: Suppl 1: 65-69.

Internet References:

  1. CMA CPG Infobase: www.cma.ca/cpgs
  2. National Library of Medicine for Clinical Practice Guidelines: http://text.nlm.nih.gov/

Link to Online Abstract at CJNS

Link to Structured Abstract of this review

Link to Summary Table of Recommendations of this review

Link to 1994 Chapter: Screening for Cognitive Impairment in the Elderly

** For a reprint of the full review, please email us your request, including your full mailing address

Top of Page

Home PageCTFPHC Home Page

Reprinted in modified format by the Canadian Task Force on Preventive Health Care
with permission.
Original Copyright © 1999 Minister of Supply and Services Canada.
For any technical issues please contact: webmaster@ctfphc.org
Last modified: February 20, 2001.